Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 529 entries
View as:

Studies of States With Resistance to Vitamin D and Parathyroid Hormone

Phase: N/A Priority: Normal
NCT ID: NCT00001242 Org: User:
Start: 08/12/97 End: 12/12/22 Due: 12/12/23

Epidemiology of Gallbladder Sludge and Stones in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT00131131 Org: User:
Start: 05/31/03 End: 12/31/09 Due: 12/31/10

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00004448 Org: User:
Start: 11/30/97 End: 08/31/07 Due: 08/31/08

Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals

Phase: N/A Priority: Normal
NCT ID: NCT01862796 Org: User:
Start: 05/31/13 End: 05/22/18 Due: 05/22/19

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Phase: N/A Priority: Normal
NCT ID: NCT00004842 Org: User:
Start: 05/31/97 End: 04/30/99 Due: 04/30/00

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase: N/A Priority: Normal
NCT ID: NCT03520660 Org: User:
Start: 10/19/18 End: 12/31/32 Due: 12/31/33

Ceramide Containing Multivesicular Emulsion Application . . .

Phase: N/A Priority: Normal
NCT ID: NCT00947726 Org: User:
Start: 07/31/09 End: - Due: -

Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00723593 Org: User:
Start: 07/23/08 End: 02/04/13 Due: 02/04/14

Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)

Phase: N/A Priority: Normal
NCT ID: NCT00082238 Org: User:
Start: 03/31/03 End: 03/31/05 Due: 03/31/06

ADD-ON Study to Existing Hypoparathyroidism Studies

Phase: N/A Priority: Normal
NCT ID: NCT00856401 Org: User:
Start: 09/30/10 End: 06/30/21 Due: 06/30/22

NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You

Phase: N/A Priority: Normal
NCT ID: NCT00007800 Org: User:
Start: 05/31/00 End: 05/31/02 Due: 05/31/03

Gabapentin to Treat Itch in Patients With Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT00058890 Org: User:
Start: 11/30/00 End: 01/31/04 Due: 01/31/05

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01441154 Org: User:
Start: 09/20/11 End: 12/12/13 Due: 12/12/14

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00006185 Org: User:
Start: 09/30/99 End: 08/31/03 Due: 08/31/04

Genetics of Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT00237081 Org: User:
Start: 06/30/04 End: 11/30/08 Due: 11/30/09

Treatment of Zollinger-Ellison Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00001241 Org: User:
Start: 01/27/89 End: 12/10/07 Due: 12/10/08

Lifestyle Interventions to Reduce Diabetes Risk

Phase: N/A Priority: Normal
NCT ID: NCT00006162 Org: User:
Start: 10/31/94 End: 04/30/99 Due: 04/30/00

Minimally Invasive Surgical Therapy for BPH

Phase: N/A Priority: Normal
NCT ID: NCT00064649 Org: User:
Start: 04/30/04 End: 06/30/06 Due: 06/30/07

Medical Therapy of Prostatic Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00021814 Org: User:
Start: 12/31/95 End: 11/30/01 Due: 11/30/02

Studies With 1,25-Dihydroxycholecalciferol

Phase: N/A Priority: Normal
NCT ID: NCT00001151 Org: User:
Start: 03/31/76 End: 10/31/09 Due: 10/31/10

Type 2 Diabetes and Obesity in Mexican Pimas: Gene-Environment Interaction

Phase: N/A Priority: Normal
NCT ID: NCT01168297 Org: User:
Start: 07/06/10 End: 08/07/20 Due: 08/07/21

Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation

Phase: N/A Priority: Normal
NCT ID: NCT00100516 Org: User:
Start: 12/23/04 End: 06/17/08 Due: 06/17/09

Study of Protein Translocation in Patients With Beta-Oxidation Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00004348 Org: User:
Start: 09/30/95 End: 03/31/98 Due: 03/31/99

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00813228 Org: User:
Start: 01/06/09 End: 11/26/19 Due: 11/26/20

Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03396484 Org: User:
Start: 09/30/20 End: 03/31/22 Due: 03/31/23